FXI News 41.47 08/14/2014 05:08:29 FTSE China 25 Index Fund Ishares

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
FTSE China 25 Index Fund Ishares (FXI) 41.47 $FXI

3 Reasons iShares China Large-Cap ETF Could Rise
Sean Williams, The Motley Fool - Motley Fool - Wed Aug 13, 1:16PM CDT
Source: Barbara Willi via Flickr. In a world with more than 6,500 different stocks available for purchase,  the sheer number of options can be overwhelming. Thankfully, exchange-traded funds can make life a bit easier for the average investor. ...

iShares FTSE Has Returned 12.1% Since SmarTrend Recommendation (FXI)
Comtex SmarTrend(R) - Tue Aug 12, 11:14AM CDT
SmarTrend identified an Uptrend for iShares FTSE (NYSE:FXI) on May 22nd, 2014 at $36.34. In approximately 3 months, iShares FTSE has returned 12.15% as of today's recent price of $40.76.

iShares FTSE Rises 1.21% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Mon Aug 11, 3:47PM CDT
iShares FTSE (NYSE:FXI) traded in a range yesterday that spanned from a low of $40.81 to a high of $41.12. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $40.57 on volume of 16.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Look for Shares of iShares FTSE to Potentially Pullback after Yesterday's 1.21% Rise
Comtex SmarTrend(R) - Mon Aug 11, 3:47PM CDT
iShares FTSE (NYSE:FXI) traded in a range yesterday that spanned from a low of $40.81 to a high of $41.12. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $40.57 on volume of 16.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Chinese Stocks Come Back To The Top Of The Heap
at Investor's Business Daily - Mon Aug 04, 5:35PM CDT
Chinese stocks have been on roll lately, and some of the leading names have found their way into the Stock Spotlight. Chinese names have generally lagged the U.S. market since the 2008 financial crisis. But iShares China Large Cap (FXI), an ETF that...

iShares FTSE Shares Up 13.4% Since SmarTrend's Buy Recommendation (FXI)
Comtex SmarTrend(R) - Tue Jul 29, 9:34AM CDT
SmarTrend identified an Uptrend for iShares FTSE (NYSE:FXI) on May 22nd, 2014 at $36.34. In approximately 2 months, iShares FTSE has returned 13.40% as of today's recent price of $41.21.

iShares FTSE Rises 2.14% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Mon Jul 28, 3:42PM CDT
iShares FTSE (NYSE:FXI) traded in a range yesterday that spanned from a low of $40.60 to a high of $41.08. Yesterday, the shares gained 2.1%, which took the trading range above the 3-day high of $40.28 on volume of 23.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

After Yesterday's Rally of 2.14% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Mon Jul 28, 3:41PM CDT
iShares FTSE (NYSE:FXI) traded in a range yesterday that spanned from a low of $40.60 to a high of $41.08. Yesterday, the shares gained 2.1%, which took the trading range above the 3-day high of $40.28 on volume of 23.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Cramer: Every Which Way But Short
at The Street - Thu Jul 24, 7:03AM CDT
In theory, there should be plenty of shorting opportunities.

Emerging Markets Outperform U.S. Equities Thanks to Latin America, China
at The Street - Wed Jul 23, 10:33AM CDT
Strong growth in China and Brazil overcome weakness in Russia.

Watch for iShares FTSE to Potentially Pullback After Gaining 2.20% Yesterday
Comtex SmarTrend(R) - Tue Jul 22, 3:46PM CDT
iShares FTSE (NYSE:FXI) traded in a range yesterday that spanned from a low of $38.98 to a high of $39.13. Yesterday, the shares gained 2.2%, which took the trading range above the 3-day high of $38.41 on volume of 17.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Watch for iShares FTSE to Potentially Rebound After Falling 1.43% Yesterday
Comtex SmarTrend(R) - Thu Jul 17, 4:22PM CDT
iShares FTSE (NYSE:FXI) traded in a range yesterday that spanned from a low of $37.91 to a high of $38.30. Yesterday, the shares fell 1.4%, which took the trading range below the 3-day low of $38.15 on volume of 18.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

After Yesterday's Decline of 1.43%, iShares FTSE Offers Investors Better Value
Comtex SmarTrend(R) - Thu Jul 17, 4:21PM CDT
iShares FTSE (NYSE:FXI) traded in a range yesterday that spanned from a low of $37.91 to a high of $38.30. Yesterday, the shares fell 1.4%, which took the trading range below the 3-day low of $38.15 on volume of 18.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Australian Stocks Threatened by Strong Currency and a Weak China
at The Street - Tue Jul 15, 2:37PM CDT
Australian equities have had a nice run in 2014, but a stronger currency, and potential weakness in China could derail the trend.

iShares FTSE Set to Possibly Pullback After Yesterday's Rally of 1.32%
Comtex SmarTrend(R) - Mon Jul 14, 3:49PM CDT
iShares FTSE (NYSE:FXI) traded in a range yesterday that spanned from a low of $38.26 to a high of $38.42. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high of $38.03 on volume of 20.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

3 China ETFs Surging Higher - ETF News And Commentary
Zacks Equity Research - ZACKS - Thu Jul 10, 9:00AM CDT
These Chinese ETFs are leading the nation higher.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Klarna’s Cash Burn Puts Disclosure Questions in Focus

Updated Category News Views 76

A $383 million operating cash drain can turn a growth story sour in a hurry. Klarna Group plc delivered exactly that kind of unpleasant jolt in its third-quarter 2026 report: a net loss of $65 million, or roughly $0.19 per share, alongside negative operating cash flow of $383 million over the first nine months of 2026. The per-share loss landed worse than the $0.13 to...

Continue Reading
Gene Editing’s Steady Revenue Engine Is Taking Shape

Updated Category News Views 112

Gene editing is finally starting to look less like a science-fair moonshot and more like a working supply chain. That distinction matters. The latest market estimate puts the global gene editing market at $5.23 billion in 2026 and projects $8.49 billion by 2031, a 10.1% compound annual growth rate. Respectable growth, certainly, but the real investment story is not a...

Continue Reading
LianLian XWorker Brings AI Agents Into Global Payments

Updated Category News Views 110

Most AI launches promise a clever helper; this one wants the helper holding a tightly controlled wallet. Lianlian DigiTech unveiled LianLian XWorker at Singapore FinTech Festival 2026 on November 19, pitching an AI Workforce platform that joins task-running agents with its global financial plumbing. That is a much more consequential proposition than another chatbot that...

Continue Reading
RUDSAK Tests Premium Demand From Toronto to New York

Updated Category News Views 145

A coat rack on Bloor Street can tell a harsher story than a glossy expansion announcement. RUDSAK has opened a Toronto flagship at 55 Bloor Street West in the Manulife Centre and is preparing a boutique at American Dream outside New York City. This is a real step up in retail ambition for the Montréal luxury outerwear house, founded in 1994, and it deserves more than the...

Continue Reading
Adcendo’s Early Sarcoma Data Earns a Careful Look

Updated Category News Views 71

Sarcoma data rarely gives anyone permission to pound the table, yet Adcendo’s first look at ADCE-D01 deserves more than a polite nod. In advanced soft tissue sarcoma, where patients have often run through the usual options and second-line response rates historically sit around 4% to 10%, a reported 30% objective response rate on the every-two-week schedule is...

Continue Reading
Compounded Peptides Demand Clearer FDA Status Answers

Updated Category News Views 73

Peptide talk has gotten muddled enough to make plain English feel revolutionary. The central point in the HelloNation article featuring wellness expert Andres Giraldo is straightforward: a compounded peptide is not FDA approved in the same product-specific manner as a commercially manufactured drug. That is not a small semantic wrinkle, and it should not be buried beneath...

Continue Reading
Why Professional Collaboration May Matter More in AI

Updated Category News Views 43

Three smart professionals can still hand a client a mess when nobody owns the handoff. That unglamorous reality sits behind the Professional Collaboration Institute, or PCI, which Sarano and Brooke Kelley plan to launch in a virtual briefing on December 2. The outfit wants to turn cross-profession coordination into a teachable, measurable discipline rather than leave it...

Continue Reading
Dental Exams Are Routine Until They Catch Something Early

Updated Category News Views 60

A mouth can look perfectly fine right up until it does not. That is the unglamorous value in the dental exam and X-rays visit described by Dr. Eric Runyon of Smiles Unlimited in Belton, Missouri: it is a structured look for trouble before pain, swelling, or a cracked tooth forces the issue. Nobody throws a parade for preventive care, but waiting for symptoms has a habit...

Continue Reading
Institutions Spread AI Bets as 2027 Risks Mount Higher

Updated Category News Views 89

Money managers are not fleeing the party; they are checking the fire exits. Natixis Investment Managers surveyed 515 institutions overseeing $42.7 trillion, and their 2027 posture is pretty plain: keep taking risk, just stop pretending every risk is the same. Inflation, rates, government debt, geopolitical fracture and an AI spending boom are all tugging at portfolios at...

Continue Reading
Lowe's Dec. 9 Conference Puts Strategy on the Clock

Updated Category News Views 148

A Calendar Entry With Real Weight December 9 is not earnings day, but it is the sort of date shareholders ought to circle anyway. Lowe's plans to hold its 2026 Analyst and Investor Conference at 8 a.m. Eastern time in New York City, with a live webcast available for those not sitting in the room. For owners of NYSE:LOW, these gatherings can be more useful than the usual...

Continue Reading
es